My Portfolio

Novartis AG NVS:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 4:00 PM EDT

143.66UNCH (UNCH)

Volume

18,926

143.66

+0.18 (+0.13%)

Volume

1,495,922

52 week range

112.34 - 170.46

Open142.47
Day High144.26
Day Low142.26
Prev Close143.48
52 Week High170.46
52 Week High Date02/27/26
52 Week Low112.34
52 Week Low Date08/01/25

Latest On Novartis AG

Weight-loss wars go global as Novo Nordisk bets big on its Wegovy pillMay 18, 2026CNBC.com
CNBC Daily Open: May Day dawnsMay 1, 2026CNBC.com
CNBC Daily Open: ‘Sell in May’ comes early?April 30, 2026CNBC.com
UK's biggest drugmakers see profit bump, as pharma grapples with U.S. policiesApril 29, 2026CNBC.com
CNBC Daily Open: UAE leaves OPEC adriftApril 29, 2026CNBC.com
Novartis CEO on Q1 earnings missApril 28, 2026CNBC.com
Watch CNBC's full interview with Novartis CEO Vas NarasimhanApril 28, 2026CNBC.com
Novartis CEO warns reality of Trump's drug pricing policy will set in over 'the next 18 months'April 28, 2026CNBC.com
Novartis CEO: We knew these first two quarters would be bumpyApril 28, 2026CNBC.com
CNBC Daily Open: Hawkish hold from BOJ sets central bank stageApril 28, 2026CNBC.com

Key Stats

Market Cap292.322B
Shares Out2.03B
10 Day Average Volume1.36M
Dividend4.74
Dividend Yield3.30%
Beta0.47

Latest On Novartis AG

Weight-loss wars go global as Novo Nordisk bets big on its Wegovy pillMay 18, 2026CNBC.com
CNBC Daily Open: May Day dawnsMay 1, 2026CNBC.com
CNBC Daily Open: ‘Sell in May’ comes early?April 30, 2026CNBC.com
UK's biggest drugmakers see profit bump, as pharma grapples with U.S. policiesApril 29, 2026CNBC.com
CNBC Daily Open: UAE leaves OPEC adriftApril 29, 2026CNBC.com
Novartis CEO on Q1 earnings missApril 28, 2026CNBC.com
Watch CNBC's full interview with Novartis CEO Vas NarasimhanApril 28, 2026CNBC.com
Novartis CEO warns reality of Trump's drug pricing policy will set in over 'the next 18 months'April 28, 2026CNBC.com
Novartis CEO: We knew these first two quarters would be bumpyApril 28, 2026CNBC.com
CNBC Daily Open: Hawkish hold from BOJ sets central bank stageApril 28, 2026CNBC.com

KEY STATS

Open142.47
Day High144.26
Day Low142.26
Prev Close143.48
52 Week High170.46
52 Week High Date02/27/26
52 Week Low112.34
52 Week Low Date08/01/25
Market Cap292.322B
Shares Out2.03B
10 Day Average Volume1.36M
Dividend4.74
Dividend Yield3.30%
Beta0.47

RATIOS/PROFITABILITY

EPS (TTM)6.98
P/E (TTM)20.59
Fwd P/E (NTM)16.10
EBITDA (TTM)23.187B
ROE (TTM)35.21%
Revenue (TTM)56.256B
Gross Margin (TTM)75.41%
Net Margin (TTM)24.02%
Debt To Equity (MRQ)121.66%

EVENTS

Earnings Date07/18/2026(est)
Ex Div Date03/11/2026
Div Amount4.7402
Split Date-
Split Factor-

Content From Our Affiliates

FDA issues draft guidance to help accelerated cell, gene therapies for patientsJune 2, 2026TipRanks
Novartis announces 144-week data from ASC4FIRST trial of ScemblixJune 1, 2026TipRanks
Novartis announces results on rPFS improvements across subgroups with PluvictoMay 31, 2026TipRanks
Deutsche Bank Keeps Their Buy Rating on Novartis AG (NOVN)May 27, 2026TipRanks
3 Vanguard Dividend ETFs to Boost Passive Income in 2026May 21, 2026TipRanks

Profile

Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided...

Giovanni Caforio M.D.

Non-Executive Independent Chairman of the Board

Vasant Narasimhan M.D.

Chief Executive Officer, Member of the Executive Committee

Mukul Mehta

Chief Financial Officer, Member of the Executive Committee

Address

Lichtstrasse 35

Basel

4056

Switzerland

https://www.novartis.com/